FGI Industries Ltd. (FGI) Spending and interest coverage
- R&D / revenue · 12 months: Value 1.01%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.11%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 1.01% | Research and development expense / revenue. Period ending 2026-06-30. $1.31M ÷ $128.70M × 100 ≈ 1.01% |
| Stock-based compensation / revenue · 12 months | 0.11% | Share-based compensation / revenue. Period ending 2026-06-30. $139.11K ÷ $128.70M × 100 ≈ 0.11% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 1.31M USD | Research and Development Expense |
| Revenue | 128.70M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 139.11K USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 420.32K USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.31M | $128.70M | $139.11K | $420.32K | (m) | 1.01% | 0.11% | (m) | (m) |
| 2026-03-31 | $1.38M | $127.82M | $140.48K | $-1.81M | (m) | 1.08% | 0.11% | (m) | (m) |
| 2025-12-31 | $1.42M | $130.53M | $333.18K | $-2.40M | (m) | 1.09% | 0.26% | (m) | (m) |
| 2025-09-30 | $1.48M | $135.65M | $179.60K | $-3.01M | (m) | 1.09% | 0.13% | (m) | (m) |
| 2025-06-30 | $1.65M | $135.90M | $274.06K | $-3.44M | (m) | 1.21% | 0.20% | (m) | (m) |
| 2025-03-31 | $1.70M | $134.28M | $357.94K | $-3.06M | (m) | 1.26% | 0.27% | (m) | (m) |
| 2024-12-31 | $1.70M | $131.82M | $401.22K | $-2.10M | (m) | 1.29% | 0.30% | (m) | (m) |
| 2024-09-30 | $1.53M | $127.18M | $622.68K | $408.28K | (m) | 1.20% | 0.49% | (m) | (m) |
| 2024-06-30 | $1.50M | $121.01M | $473.51K | $955.80K | (m) | 1.24% | 0.39% | (m) | (m) |
| 2024-03-31 | $1.35M | $120.83M | $417.84K | $1.99M | $722.30K | 1.11% | 0.35% | 2.75× | Reported |
| 2023-12-31 | $1.38M | $117.24M | $417.98K | $2.30M | $749.73K | 1.17% | 0.36% | 3.07× | Reported |
| 2023-09-30 | $1.42M | $118.08M | $454.81K | $2.06M | $762.30K | 1.20% | 0.39% | 2.71× | Reported |
| 2023-06-30 | $1.23M | $126.69M | $511.39K | $3.25M | $904.95K | 0.97% | 0.40% | 3.59× | Reported |
| 2023-03-31 | $1.09M | $145.31M | $463.48K | $4.40M | $718.68K | 0.75% | 0.32% | 6.12× | Reported |
| 2022-12-31 | $1.05M | $161.72M | $383.57K | $5.09M | $600.80K | 0.65% | 0.24% | 8.48× | Reported |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $646.07K | $181.94M | (m) | $7.72M | $411.19K | 0.36% | (m) | 18.79× | Reported |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omega Flex, Inc. (OFLX) | United States | $0.254B | 26.69 |
| MASCO CORP /DE/ (MAS) | United States | $13.575B | 14.55 |